What are the differences between innovative drug companies and generic drug companies in formulating patent strategies?

Drug patent strategy refers to the overall strategy of pharmaceutical enterprises to make full use of patent system and seek the maximization of economic benefits of enterprises.

Its essence is to apply the characteristics of enterprise patent strategy to the pharmaceutical industry. The subject of pharmaceutical patent strategy is pharmaceutical enterprises, and the object is the legal and effective patent right owned by the subject.

At present, more and more enterprises raise intellectual property to the strategic level of enterprises, and regard it as the key to grasp the initiative of development. By strengthening the management and application of intellectual property rights, the core competitiveness of enterprises can be enhanced. Patent analysis plays an indispensable role in the formulation of competitive strategy for enterprises and plays a decisive role!

From project establishment, infringement risk assessment to market prospect prediction, intellectual property rights and R&D need close cooperation, and people who work in enterprises with R&D background have an advantage.

Whether it is a product company, a technology company or even a service company, you should think about your IP strategy.